How to Negotiate Managed Medicaid Contracts to Improve Mental Health Care Access

When it comes to the issue of mental health care and substance use treatment, it’s imperative that states properly negotiate mental health and addiction parity protections into contracts with managed care organizations (MCOs) administering Medicaid plans. This includes empowering providers to challenge denials of medically necessary care.

To help promote timely and appropriate care for Medicaid recipients, the National Council for Behavioral Health has released an article outlining suggested contractual language that state Medicaid directors should consider when they negotiate managed care contracts. The primer is co-authored by Psych-Appeal’s Meiram Bendat.

“The potential confusion regarding the Mental Health Parity and Addiction Equity Act compliance requirements for Managed Care Organizations (‘MCOs’) in the Medicaid sector, as well as the often complicated medical necessity determination and appeal procedures may jeopardize an individual’s ability to obtain medically necessary care,” write the authors. “It is imperative that states negotiating Medicaid contracts with MCOs make use of new safeguards and mental health and addiction parity protections to ensure access to essential services for vulnerable populations. This includes empowering providers to effectively challenge adverse benefit determinations impacting their patients’ access to medically necessary care.”

In “Protecting Consumer Access to Mental Health and Addiction Care in Managed Medicaid Plans,” Bendat and the National Council for Behavioral Health outline eight points of discussion, along with proposed contract terms, that are focused on the appeals process and plan disclosure requirements:

  1. Communications,
  2. Standing,
  3. Access to plan documents,
  4. Access to clinical criteria,
  5. Network access,
  6. Negotiated coverage modifications,
  7. Access to claims data, and
  8. Denials implicating mental health and addiction parity.

These recommendations serve as a useful guide in clarifying the rights, expectations and responsibilities of all parties, including states, MCOs, patients and providers.

Psych-Appeal and the National Council for Behavioral Health have also compiled tips on how providers can negotiate contracts with MCOs.

 

NOTE: “Protecting Consumer Access to Mental Health and Addiction Care in Managed Medicaid Plans” is for educational purposes only. The incorporation of any of these recommendations into managed care contracts should be decided upon after consultation with qualified legal counsel.

Enforcing Mental Health Parity: Progress and Challenges

Last fall, Health Affairs published “Enforcing Mental Health Parity.” The health policy brief may no longer be hot off the press, but it’s still very relevant. The seven-page paper offers an excellent snapshot of how far we’ve come as a nation in addressing mental health parity—and how much we have left to do to ensure that it becomes a reality for the millions of Americans who suffer from mental health and substance use conditions.

The Health Affairs paper outlines congressional action from the 1996 Mental Health Parity Act (MHPA) to the 2008 Mental Health Parity and Addiction Equity Act (MHPAEA) to the Affordable Care Act (ACA). It then looks at the ongoing challenges of enforcement and various class-action lawsuits that have been filed on behalf of patients for parity violations, including New York State Psychiatric Association, Inc. et al. v. UnitedHealthGroup et al.

“While there have been some improvements since the law passed, access to timely, in-network mental health and substance use providers remains a problem,” states the brief.

We agree.

Court Certifies Wit v. UBH Class Action Challenging Mental Health Criteria

In a significant mental health ruling, the United States District Court for the Northern District of California has certified Wit v UBH as a class action. With this decision, the federal court has come one step closer to ordering health insurance giant United Behavioral Health (“UBH”) to revamp its medical necessity criteria and reprocess thousands of outpatient, intensive outpatient and residential treatment claims it denied since 2011.

Plaintiffs in two companion class-action lawsuits, Wit et al. v. UnitedHealthcare et al. and Alexander et al. v. United Behavioral Health (referred to collectively as “Wit v UBH”) allege that UBH systematically denies coverage for mental health treatment by developing and applying “medical necessity” criteria that are far more stringent than generally accepted standards of care.

“This class certification order is an important victory in the fight for mental health parity,” said Psych-Appeal’s Meiram Bendat, co-counsel for the plaintiffs. “It signals that health insurers can be held responsible, on a class-wide basis, for denying insurance coverage for mental health treatment to those desperately in need. Without class certification, few, if any, patients will have the financial or emotional resources necessary to challenge this type of misconduct individually.”

The plaintiffs’ health plans, governed by the Employee Retirement Income Security Act (ERISA), require UBH to evaluate medical necessity according to generally accepted standards of care. UBH’s proprietary medical necessity criteria purport to reflect these standards. However, the plaintiffs allege that a push for profits has led UBH to develop criteria that overemphasize acute mental health and substance use disorder symptoms and disregard chronic or complex conditions that require ongoing care, in contravention of generally accepted standards.

UBH is a subsidiary of UnitedHealth Group and is the country’s largest managed behavioral health care organization, serving more than 60 million members.

In addition to Wit v UBH, Psych-Appeal and Zuckerman Spaeder LLP have been appointed class counsel by the federal court and also represent plaintiffs in similar mental health parity cases against Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, Texas, New Mexico, Montana and Oklahoma), Magellan Health Services of California and Blue Shield of California.

KQED: Psych-Appeal’s Meiram Bendat on Mental Health Accessibility in California

NPR member station KQED is looking into the “State of Mind” in California with an investigation into the accessibility of mental health treatment—and the ramifications of denials and gaps in coverage. As part of the series, reporter April Dembosky spoke to Psych-Appeal’s Meiram Bendat about the Department of Managed Health Care’s relationship with insurance companies.

“Why don’t we have the same type of enforcement as we do [in New York]?” asks Bendat. “They’re a slow bureaucracy that takes way too long to respond to consumer complaints.”

Bendat’s comments are part of a broader story examining state regulation that aired today on KQED.

Magellan, Blue Shield of California Lawsuit Alleges Improper Denial of Care to Teens

Psych-Appeal, Grant & Eisenhofer P.A., and Zuckerman Spaeder LLP have filed a class-action lawsuit against Magellan and Blue Shield of California on behalf of adolescents suffering from mental health and substance use disorders. The suit alleges that the health insurers limit and deny coverage for outpatient and residential treatment using strict guidelines that are created internally by Magellan.

“These guidelines by Magellan and Blue Shield of California are far more restrictive than the standards of care that are generally accepted within the mental health community,” said Meiram Bendat, president of Psych-Appeal. “When insurers develop criteria that distort or disregard generally accepted treatment standards, profitability trumps patient safety.”

The plaintiffs in the case include a father whose teenage son was denied residential treatment for substance abuse and major depression, and a mother whose son was denied intensive outpatient treatment for the same conditions.

The complaint was filed in the U.S. District Court, Northern District of California.

California DMHC Sued for Unlawful Handling of Mental Health Appeals

With Psych-Appeal as its counsel, Evolve Growth Initiatives LLC has filed a first-of-its-kind lawsuit against the California Department of Managed Health Care and its director, Shelley Rouillard. The lawsuit seeks to compel DMHC to follow a 16-year-old state law requiring DMHC to promptly process expedited appeals when health care coverage, including mental health treatment, is denied.

“Expedited appeals submitted to DMHC are critical for patients who have been denied mental health care and need a final coverage decision before they can get approved for treatment,” explained Meiram Bendat of Psych-Appeal. “The consequences of not receiving a timely decision can be devastating since patients must decide whether to pay for costly treatments out of pocket, with the very real possibility of not getting reimbursed – or simply say ‘no’ and forego the care they desperately need.”

DMHC regulates health plans that cover more than 25 million Californians. Under California law, DMHC is required to immediately process urgent appeals of health plan denials, and to generally provide decisions within three days. The lawsuit cites examples of patients and providers waiting up to six weeks for determinations.

“The longer it takes to receive urgent appeal decisions, the greater the harm to patients and to providers,” said Mendi Baron, CEO at Evolve, which operates adolescent mental health and substance abuse treatment facilities in California and New York. “While Evolve does not discharge patients pending appeals, we find that if they can’t pay for treatment themselves, many patients simply won’t stay in treatment. Also, mental health providers often delay or terminate care instead of taking on the risks associated with these delayed appeals. DMHC may tout mental health parity, but its practices are making a mockery of actual mental health care.”

Evolve Growth Initiatives, LLC v. California Department of Managed Health Care, et al. was filed yesterday afternoon in the Los Angeles County Superior Court. In addition to allegations that DMHC routinely violates the statutory and regulatory deadlines established for expedited appeals, the lawsuit asserts that DMHC has attempted to cover up its unlawful practices by failing, over many months, to produce relevant documents and data in response to Evolve’s California Public Records Act request.

Related coverage:

Clinic sues state health agency for illegal delaysDaily Journal, February 25, 2016

California Regulator Sued over Delayed Mental Health Appeals, KQED (NPR), February 24, 2016

Mental Health State of the Union Champions the "System We Need"

Today’s second annual State of the Union in Mental Health and Addiction called for changing public discourse on mental health as well as establishing a comprehensive “System We Need” to help achieve full implementation of the Parity Act.

“We’re here to set a political agenda, not a medical agenda,” said former Rep. Patrick Kennedy, founder of The Kennedy Forum, during his State of the Union speech. “I’m proud to be part of that march for progress.”

Kennedy continued, saying that he is involved in efforts to have a presence at the upcoming Democratic and Republican national conventions, and will petition for changes in party platforms.

Kennedy also outlined the behavioral health “System We Need” to improve on mental health care and ensure integrated delivery of that care.

“We cannot build the system we need unless we break the silence,” said Kennedy.

The second annual State of the Union in Mental Health and Addiction was hosted by The Kennedy Forum and the Satcher Health Leadership Institute. Follow the conversation on Twitter at #MHSOTU.

Patrick Kennedy’s “A Common Struggle” Focuses National Attention on Mental Health

With the release of Patrick Kennedy’s new book, “A Common Struggle,” mental health and parity (or lack thereof) are at the forefront of conversations, sparking dialogue and discussion across the nation.

The book’s status as an instant New York Times bestseller is heartening as it raises awareness of mental health illness and the devastating impact it often has on family, friends and communities. In calling for unity to end all forms of discrimination surrounding mental health, Kennedy gives a candid portrait of his own struggles with addiction and bipolar disorder. And he offers hope that the laws of today can achieve true parity.

“The Mental Health Parity Act is the equivalent of a medical civil rights act, a brain disease equal rights amendment—the legal end of the discrimination that is at the heart of the stigma of brain diseases,” writes Kennedy. “Our children must be part of the first generation for which routine doctor visits include a ‘checkup from the neck up.'”

Psych-Appeal is honored that our work is mentioned in “A Common Struggle.” We will continue our mission-based goal of advocating for patient rights and expanding access to mental health treatment.

Meiram Bendat Gives Parity Seminar at Yale Medical School

Psych-Appeal founder Meiram Bendat gave an hour-long seminar today at Yale School of Medicine. His presentation, titled “Addressing Treatment Incursions by Insurers in the Era of Mental Health Parity,” covered an array of issues applicable to mental health parity, from federal parity rules and regulatory enforcement to the scrutinization of insurer denials.

“We certainly don’t penalize people in the medical context for obesity by denying them care for diabetes down the road,” remarked Bendat during the presentation. “So why should we do anything different in this capacity?”

When reviewing an insurer’s denial of mental health treatment, Bendat urged attendees to compare the insurer’s criteria with generally accepted criteria, including state-mandated criteria as well as physician specialty association guidelines issued by the American Society of Addiction Medicine (ASAM) and the American Academy of Child and Adolescent Psychiatry (AACAP).

We thank all those who attended and contributed to the thoughtful discourse. The seminar was hosted by Yale School of Medicine’s Department of Psychiatry Grand Rounds.

Class Action Filed Against Cigna for Denying Depression Treatment

A class-action lawsuit has been filed against Cigna by Psych-Appeal, in conjunction with Zuckerman Spaeder LLP, on behalf of mental health patients suffering from depression. The federal lawsuit alleges Cigna has categorically refused to cover Transcranial Magnetic Stimulation (“TMS”), a safe and effective treatment approved by the U.S. Food and Drug Administration. The filing was made days after Psych-Appeal and Zuckerman Spaeder LLP filed a similar class action complaint against Aetna on September 3.

“Although Medicare and numerous commercial insurers routinely cover TMS, Cigna has unjustifiably categorized this treatment as ‘experimental and investigational,’” said Brian Hufford, partner at Zuckerman Spaeder LLP. “By denying coverage for TMS and restricting patients from receiving potentially lifesaving treatment, Cigna is improperly elevating its own interests above the welfare of its members.”

The suit involves a 61-year-old woman who has tried multiple treatments for her severe depression. In 2008, the FDA cleared TMS for patients who have failed to respond to psychotropic medications. TMS, unlike electroshock therapy, is performed on an outpatient basis without sedation and does not typically result in side effects such as memory loss.

The complaint also alleges that MCMC, LLC, an independent review organization directly contracted with Cigna to evaluate external appeals of the company’s TMS denials, rubber-stamps the insurer by relying on outdated clinical research.

“In California alone, at least 75 external appeals to other independent review organizations have recognized TMS as a valid, evidence-based treatment for depression since 2011,” said Meiram Bendat, mental health attorney and founder of Psych-Appeal. “We expect this case to highlight the conflicts of interest that independent review organizations have when they are allowed to contract directly with insurers to evaluate claim denials.”

Related coverage:

Cigna Sued for Allegedly Denying Depression Treatment, Bloomberg Law, September 14, 2015